医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Clinlogix Launches Asia-Pacific Division with Opening of Offices in Singapore and Tokyo

2016年02月10日 PM09:30
このエントリーをはてなブックマークに追加


 

SPRING HOUSE, Pa.

Leading contract research organization Clinlogix, a full suite provider of clinical development services for medical device and biopharmaceutical customers, announces the launch of their new Asia-Pacific operations with staffed office openings in Singapore and Tokyo, Japan. The expansion into the Asia-Pacific market allows the company to extend and provide its tailored clinical development services via feet-on-the-ground staff with deep, country-specific expertise in both regulatory processes and partnering with clinical study sites to achieve its life science clients’ goals.

Clinlogix Asia Pacific is led by Managing Director Joalin Lim, PhD, who has more than 20 years of clinical and regulatory experience in Japan, China, Australia, Korea and rest of the Asia-Pacific market. Lim’s experience in clinical operations, regulatory affairs, health economics and reimbursement for prior companies such as Quintiles, Covidien and Abbott, among others, position her well for this role with Clinlogix. The team has significant experience in the region managing multi-center cardiovascular medical device clinical studies.

“The launch of the Asia-Pacific division allows Clinlogix to expand and deliver the customized, hands-on, quality clinical research services our global customers have come to expect from our other operations around the globe in the U.S., Europe and South America,” said JeanMarie Markham, Clinlogix CEO. “This will enable us to provide proper training, oversight and further develop our partnerships with clinical sites in these markets, which is vital to ensuring both the regulatory and clinical development success of our clients’ emerging medical technologies.”

About Clinlogix

Clinlogix is a global clinical research organization supporting innovation in the life science industry. Its full suite of clinical research services support the regulatory and clinical development pathway of medical devices, pharmaceuticals, biologics and diagnostics. Clinlogix is the premier partner from proof of concept/discovery, early feasibility/first-in-human, through pivotal and the post-marketing/safety surveillance of client products. The Company delivers global expertise by way of regional office locations in the US – Spring House, Pennsylvania; Europe – London, UK and Mainz, Germany; South America – Medellin, Colombia; and Asia – Singapore and Tokyo, Japan.

Learn more at www.clinlogix.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160210005337/en/

CONTACT

Clinlogix
Michael O’Gorman, 215-855-9054 x 7002
mogorman@clinlogix.com
or
Media:
Brandwidth
Solutions
Debra Harrsch, 267-577-0806
dharrsch@brandwidthsolutions.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 国际纳米技术展览暨研讨会——2017纳米科技展将为您带来尖端技术与材料的最新资讯,令超智能社会触手可及
  • Takeda and Ovid Therapeutics Announce Innovative Clinical Development and Commercialization Collaboration for TAK-935 in Rare Pediatric Epilepsies
  • Bioventus选择MEDSERVICE作为DUROLANE®在俄罗斯的经销商
  • “nano tech 2017 国際ナノテクノロジー総合展・技術会議”開催、超スマート社会の実現に貢献する最先端技術・材料の最新情報を発信!
  • nano tech 2017, the International Nanotechnology Exhibition & Conference, Brings You the Latest Information on the Cutting Edge Technologies and Materials Making the Super Smart Society a Reality